Dr Reddys Laboratories (RDY) Profit After Tax Growth (1y) (2010 - 2021)
Dr Reddys Laboratories (RDY) Profit After Tax Growth (1y) (2010 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -303.53% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -17.27% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 34.32% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | -99.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 28.85% |
| Mar 31, 2021 | -2.53% |
| Sep 30, 2020 | -214.71% |
| Jun 30, 2020 | -32.03% |
| Mar 31, 2020 | -32.48% |
| Sep 30, 2019 | -2.86% |
| Jun 30, 2019 | 131.82% |
| Mar 31, 2019 | 85.71% |
| Dec 31, 2018 | 43.18% |
| Sep 30, 2018 | 32.08% |
| Dec 31, 2017 | 100.00% |
| Sep 30, 2017 | -38.37% |
| Dec 31, 2016 | -65.63% |
| Sep 30, 2016 | -1.15% |
| Dec 31, 2015 | -16.88% |
| Sep 30, 2015 | -11.22% |
| Dec 31, 2014 | -18.95% |
| Sep 30, 2014 | -46.15% |
| Mar 31, 2014 | 50.82% |
| Dec 31, 2013 | -9.52% |